Vitamin D Effect on Ultrasonography and Laboratory Indices and Biochemical Indicators in the Blood: an Interventional Study on 12 to 18-Year-Old Children with Fatty Liver
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The rising prevalence of childhood obesity in the past decades has caused nonalcoholic fatty liver disease (NAFLD) to become the most common cause of pediatric chronic liver disease worldwide. This study was aimed at determining the effect of vitamin D (Vit D) on ultrasonography and laboratory indices of NAFLD and some blood biochemical indicators in children. Methods: In this interventional study liver ultrasonography was performed in 200 children with overweight and obesity. A 108 had fatty liver among which 101 were randomly divided into two groups of study (n=51) and control (n=50). The study group was treated with Vit D, 50000 U once a week whereas the control group received placebo with the same dose and package, both for 12 weeks. At the end of the intervention lab tests and ultrasound study was performed once again to evaluate the response to treatment. Results: It was found out that Vit D supplementation improved the fatty liver grade in the study group. The mean changes in hemoglobin (Hb), uric acid, highdensity lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), insulin, albumin and alanine aminotransferase (ALT) was significantly higher in the study group compared to controls (p<0.05). After the intervention and means adjustment, a significant difference was obtained in HDL-C, insulin, LDL-C and homeostasis model assessment of insulin resistance (HOMA-IR) between the two groups. Conclusion: Vit D supplementation in addition to improving the fatty liver grade in ultrasonography and increasing the blood Vit D level, increases the HDL and Hb level besides decreasing uric acid, LDL, HOMA-IR, insulin and ALT levels.
Abstract
Purpose: The rising prevalence of childhood obesity in the past decades has caused nonalcoholic fatty liver disease (NAFLD) to become the most common cause of pediatric chronic liver disease worldwide. This study was aimed at determining the effect of vitamin D (Vit D) on ultrasonography and laboratory indices of NAFLD and some blood biochemical indicators in children. Methods: In this interventional study liver ultrasonography was performed in 200 children with overweight and obesity. A 108 had fatty liver among which 101 were randomly divided into two groups of study (n=51) and control (n=50). The study group was treated with Vit D, 50000 U once a week whereas the control group received placebo with the same dose and package, both for 12 weeks. At the end of the intervention lab tests and ultrasound study was performed once again to evaluate the response to treatment. Results: It was found out that Vit D supplementation improved the fatty liver grade in the study group. The mean changes in hemoglobin (Hb), uric acid, highdensity lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), insulin, albumin and alanine aminotransferase (ALT) was significantly higher in the study group compared to controls (p<0.05). After the intervention and means adjustment, a significant difference was obtained in HDL-C, insulin, LDL-C and homeostasis model assessment of insulin resistance (HOMA-IR) between the two groups. Conclusion: Vit D supplementation in addition to improving the fatty liver grade in ultrasonography and increasing the blood Vit D level, increases the HDL and Hb level besides decreasing uric acid, LDL, HOMA-IR, insulin and ALT levels.
참고문헌 (36)
- de Onis M, "Global prevalence and trends of overweight and obesity among preschool children", Am J Clin Nutr, 92, pp.1257~1264 (2010)
- Yildiz I, "Role of vitamin D in children with hepatosteatosis", J Pediatr Gastroenterol Nutr, 59, pp.106~111 (2014)
- Low S, "Review on epidemic of obesity", Ann Acad Med Singap, 38, pp.57~59 (2009)
- Malespin M, "Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese American children", J Clin Gastroenterol, 49, pp.345~349 (2015)
- Burke A, "Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation", Am J Transplant, 4, pp.686~693 (2004)
- Di Sessa A, "The membrane-bound O-Acyltransferase7 rs641738 variant in pediatric nonalcoholic fatty liver disease", J Pediatr Gastroenterol Nutr, 67, pp.69~74 (2018)
- Khadaee GH, "Increases of obesity and overweight in children : an alarm for parents and policymakers", Int J Pediatr, 4, pp.1591~1601 (2016)
- Della Corte C, "Docosahexanoic acid plus vitamin D treatment improves features of NAFLD in children with serum vitamin D deficiency: results from a single centre trial", PLoS One, 11, pp.e0168216~ (2016)
- Papandreou D, "Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease", Appetite, 59, pp.939~944 (2012)
- Walker RW, "Genetic and dietary determinants of nonalcoholic fatty liver disease in Hispanic children", PhD, pp.2013
- Trappoliere M, "The treatment of NAFLD", Eur Rev Med Pharmacol Sci, 9, pp.299~304 (2005)
- Farrell GC, "Nonalcoholic fatty liver disease: from steatosis to cirrhosis", Hepatology, 43(2 Suppl 1), pp.S99~S112 (2006)
- Palomer X, "Role of vitamin D in the pathogenesis of type 2 diabetes mellitus", Diabetes Obes Metab, 10, pp.185~197 (2008)
- James WP, "22 Marabou symposium: the changing faces of vitamin D", Nutr Rev, 66(10 Suppl 2), pp.10~12 (2008)
- Melamed ML, "25-hydroxyvitamin D levels and the risk of mortality in the general population", Arch Intern Med, 168, pp.1629~1637 (2008)
- Foroughi M, "The effect of vitamin D supplementation on blood sugar and different indices of insulin resistance in patients with non-alcoholic fatty liver disease(NAFLD)", Iran J Nurs Midwifery Res, 21, pp.100~104 (2016)
- Shiasi-Arani K, "Frequency of metabolic syndrome and type 2 diabetes among the obese children and adolescents in Kashan during 2009-11", Feyz J Kashan Univ Med Sci, 16, pp.240~247 (2012)
- Nobili V, "Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease", Eur J Endocrinol, 170, pp.547~553 (2014)
- Maki KC, "Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women", J Clin Lipidol, 3, pp.289~296 (2009)
- Baziar N, "Effect of vitamin D supplementation on improving vitamin D levels and insulin resistance in vitamin D insufficient or defficient type2 diabetics", IJDLD, 13, pp.425~433 (2014)
- Han SS, "Non-linear relationship between serum 25-hydroxyvitamin D and hemoglobin in Korean females: the Korean National Health and Nutrition Examination Survey 2010-2011", PLoS One, 8, pp.e72605~ (2013)
- Sharma S, "The role of 25-hydroxy vitamin D deficiency in iron deficient children of North India", Indian J Clin Biochem, 30, pp.313~317 (2015)
- Takır M, "Association between elevated serum uric acid and vitamin D insufficiency among the middle-aged and elderly population", Turk Nephrol Dial Transplant J, 25, pp.182~186 (2016)
- Peng H, "Association between vitamin D insufficiency and elevated serum uric acid among middle-aged and elderly Chinese Han women", PLoS One, 8, pp.e61159~ (2013)
- Mohamed GA, "Vitamin D deficiency in knee osteoarthritis and its relationship with obesity in Saudi Arabia", Life Sci J, 12, pp.104~111 (2015)
- Kelishadi R, "Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome : a triple-masked controlled trial", J Pediatr(Rio J), 90, pp.28~34 (2014)
- Ashraf AP, "Associations of serum 25-hydroxyvitamin D and components of the metabolic syndrome in obese adolescent females", Obesity(Silver Spring), 19, pp.2214~2221 (2011)
- Gagnon C, "Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab)", J Clin Endocrinol Metab, 97, pp.1953~1961 (2012)
- Rhee EJ, "High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome", Endocr J, 60, pp.743~752 (2013)
- Katz K, "Suspected nonalcoholic fatty liver disease is not associated with vitamin d status in adolescents after adjustment for obesity", J Obes, 2010, pp.496829~ (2010)
- Tavakoli F, "Vitamin D supplementation and high-density lipoprotein cholesterol: a study in healthy school children", Iran J Pediatr, 26, pp.e3311~ (2016)
- 옥소영, "Serum 25-Hydroxyvitamin D Concentration Is Independently Inversely Associated with Insulin Resistance in the Healthy, Non-Obese Korean Population", Diabetes and Metabolism Journal, 40(5), pp.367~375 (2016), 대한당뇨병학회[DOI]
- 송보미, "Association between Serum 25-Hydroxyvitamin D Level and Insulin Resistance in a Rural Population", Yonsei Medical Journal, 55(4), pp.1036~1041 (2014), 연세대학교의과대학[DOI]
- Choi DP, "Serum 25-hydroxyvitamin D and insulin resistance in apparently healthy adolescents", PLoS One, 9, pp.e103108~ (2014)
- Pittas AG, "The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis", J Clin Endocrinol Metab, 92, pp.2017~2029 (2007)
- Amer M, "Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults(from the continuous National Health and Nutrition Examination Survey 2001 to 2006)", Am J Cardiol, 109, pp.226~230 (2012)
